Overall, these findings highlighted that PTP1B inhibition can counteract adipocyte dysfunction, which plays a crucial role in the development of insulin resistance in obesity and the metabolic syndrome [99,100]. This evidence concerns the gene PTPN1 and obesity due to melanocortin 4 receptor deficiency.